Doribax

Active Ingredient(s): Doripenem
FDA Approved: * October 12, 2007
Pharm Company: * JOHNSON AND JOHNSON
Category: Antibiotics

Doripenem (Doribax, Finibax) is an antibiotic drug in the carbapenem class. It is a beta-lactam antibiotic drug able to kill Pseudomonas aeruginosa. Doripenem can be used for bacterial infections such as: complex abdominal infections, pneumonia within the setting of a hospital, and complicated infections of the urinary tract including kidney infections with sepsis. The greater stability of doripenem in aqueous solution compared to earlier members of the carbapenem class allows it to be admin... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Doribax 500 mg/10ml Intravenous Powder, for Solution
NDC: 50458-401
Labeler:
Janssen Pharmaceuticals, Inc.
Doribax 250 mg/10ml Intravenous Powder, for Solution
NDC: 50458-402
Labeler:
Janssen Pharmaceuticals, Inc.
Doribax 250 mg/10ml Intravenous Powder, for Solution
NDC: 59630-309
Labeler:
Shionogi Inc.
Doribax 500 mg/10ml Intravenous Powder, for Solution
NDC: 59630-320
Labeler:
Shionogi Inc.